
|Articles|May 20, 2021
Process Purification Development of Retrovirus-like Particle
Author(s)Bio-Rad Laboratories
Read a case study about resin screening, process development, and scale-up purification of a retrovirus-like particle which was scalable, fast, and low-cost during the clinical-grade manufacture of retrovirus vectors.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Trending on BioPharm International
1
Challenges, Innovations, and Future Outlook of Biologics Formulations
2
A-TEEM: A Novel, Powerful Tool for Evaluating and Monitoring Cell Culture Media
3
CPHI Frankfurt 2025 Highlights Global Pharma Innovation and Manufacturing Leadership
4
Global Study Confirms Survival Advantage of Mogamulizumab in Advanced Mycosis Fungoides and Sézary Syndrome
5